Literature DB >> 33477496

Diet and PPARG2 Pro12Ala Polymorphism Interactions in Relation to Cancer Risk: A Systematic Review.

Lieu Tran1, Gerd Bobe2, Gayatri Arani1, Yang Zhang1, Zhenzhen Zhang3, Jackilen Shannon3, Yumie Takata1.   

Abstract

Peroxisome proliferator-activated receptor-γ2 gene Pro12Ala allele polymorphism (PPARG2 Pro12Ala; rs1801282) has been linked to both cancer risk and dietary factors. We conducted the first systematic literature review of studies published before December 2020 using the PubMed database to summarize the current evidence on whether dietary factors for cancer may differ by individuals carrying C (common) and/or G (minor) alleles of the PPARG2 Pro12Ala allele polymorphism. The inclusion criteria were observational studies that investigated the association between food or nutrient consumption and risk of incident cancer stratified by PPARG2 Pro12Ala allele polymorphism. From 3815 identified abstracts, nine articles (18,268 participants and 4780 cancer cases) covering three cancer sites (i.e., colon/rectum, prostate, and breast) were included. CG/GG allele carriers were more impacted by dietary factors than CC allele carriers. High levels of protective factors (e.g., carotenoids and prudent dietary patterns) were associated with a lower cancer risk, and high levels of risk factors (e.g., alcohol and refined grains) were associated with a higher cancer risk. In contrast, both CG/GG and CC allele carriers were similarly impacted by dietary fats, well-known PPAR-γ agonists. These findings highlight the complex relation between PPARG2 Pro12Ala allele polymorphism, dietary factors, and cancer risk, which warrant further investigation.

Entities:  

Keywords:  PPARG2 Pro12Ala polymorphism; cancer; diet; diet-gene interactions; nutrients; peroxisome proliferator-activated receptor-γ2

Mesh:

Substances:

Year:  2021        PMID: 33477496      PMCID: PMC7831057          DOI: 10.3390/nu13010261

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  42 in total

1.  The PPARgamma antagonist T0070907 suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.

Authors:  Yekaterina Y Zaytseva; Natalie K Wallis; R Chase Southard; Michael W Kilgore
Journal:  Anticancer Res       Date:  2011-03       Impact factor: 2.480

2.  Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism could be a risk factor for gastric cancer.

Authors:  Jing Zhao; Zheng Zhi; Guangyao Song; Juan Wang; Chao Wang; Huijuan Ma; Xian Yu; Aixia Sui; Hongtao Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2015

3.  Meat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARgamma gene and colorectal cancer risk in Japanese.

Authors:  Kiyonori Kuriki; Kaoru Hirose; Keitaro Matsuo; Kenji Wakai; Hidemi Ito; Yukihide Kanemitsu; Takashi Hirai; Tomoyuki Kato; Nobuyuki Hamajima; Toshiro Takezaki; Takeshi Suzuki; Toshiko Saito; Rie Tanaka; Kazuo Tajima
Journal:  Cancer Sci       Date:  2006-09-05       Impact factor: 6.716

4.  Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer.

Authors:  Stefano Landi; Victor Moreno; Lydie Gioia-Patricola; Elisabeth Guino; Matilde Navarro; Javier de Oca; Gabriel Capella; Federico Canzian
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

5.  Anticancer activities of PPARγ in breast cancer are context-dependent.

Authors:  Jin-Tang Dong
Journal:  Am J Pathol       Date:  2013-04-22       Impact factor: 4.307

6.  Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease.

Authors:  M Adachi; R Kurotani; K Morimura; Y Shah; M Sanford; B B Madison; D L Gumucio; H E Marin; J M Peters; H A Young; F J Gonzalez
Journal:  Gut       Date:  2006-03-17       Impact factor: 23.059

7.  Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer.

Authors:  Ulla Vogel; Jane Christensen; Marianne Dybdahl; Søren Friis; Rikke D Hansen; Håkan Wallin; Bjørn A Nexø; Ole Raaschou-Nielsen; Paal S Andersen; Kim Overvad; Anne Tjønneland
Journal:  Mutat Res       Date:  2007-04-27       Impact factor: 2.433

8.  The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases.

Authors:  Sandeep Tyagi; Paras Gupta; Arminder Singh Saini; Chaitnya Kaushal; Saurabh Sharma
Journal:  J Adv Pharm Technol Res       Date:  2011-10

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

10.  Expression of peroxisome-proliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes.

Authors:  Wen G Jiang; Anthony Douglas-Jones; Robert E Mansel
Journal:  Int J Cancer       Date:  2003-09-20       Impact factor: 7.396

View more
  1 in total

Review 1.  Influence of Psychological Factors in Breast and Lung Cancer Risk - A Systematic Review.

Authors:  Maria Angelina Pereira; António Araújo; Mário Simões; Catarina Costa
Journal:  Front Psychol       Date:  2022-01-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.